Overview

The Effect of 3 Ropivacaine Suprascapular Nerve Blocks in Subacute Adhesive Capsulitis: a Randomized Controlled Trial

Status:
Completed
Trial end date:
2020-09-30
Target enrollment:
0
Participant gender:
All
Summary
Patients presenting with subacute, less than 6 months of evolution, adhesive capsulitis are randomly attributed to the control or study group. Both groups receive a series of 3 suprascapular nerve blocks under ultrasound guidance with either 5ml saline or 5ml ropivacaine 2mg/ml ( ref) at 1 week interval. Testing consists of glenohumeral range of motion (ROM) (anterior elevation, lateral elevation, external and internal rotation) measured by goniometer, Constant score and visual analog scale (VAS) pain score. Evaluations are done immediately before and one hour after every suprascapular block and at 4 weeks after the third suprascapular block. All suprascapular nerve blocks are performed by one physician and the evaluations are done by a occupational therapist or MD experienced in glenohumeral function evaluations. All practitioners are blinded to the assigned group. All patients continue their pre-study treatment of physiotherapy and per os pain medication. Patients keep a record of analgesics and NSAID use during the trial. Drop-out rate is measured.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Clinique Saint-Jean, Bruxelles
Collaborator:
University Hospital St Luc, Brussels
Treatments:
Ropivacaine
Criteria
Inclusion Criteria:

- subacute adhesive capsulitis: pain evolving for less than 6 months before enrollment

Exclusion Criteria:

- other conditions involving the shoulder ( rheumatoid or septic arthritis, Hill-Sachs
lesions,osteoarthritis of the shoulder, or malignancies in the shoulder region);

- neurologic deficits affecting shoulder function in normal daily activities (such as
history of stroke, multiple sclerosis, parkinson disease...)

- shoulder pain caused by cervical radiculopathy

- a history of drug allergy to ropivacaïne

- pregnancy or lactation

- cognitive impairment with inability to fill out a protocol